NCT07178847View on ClinicalTrials.gov

cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas

NANot yet recruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

July 31, 2031

Conditions
Locally Advanced Head and Neck Carcinoma
Interventions
BIOLOGICAL

blood sampling

The intervention consist in blood samples (18mL) collected 1 and 3-months after the end of chemoradiotherapy

Trial Locations (3)

63011

Centre Jean PERRIN, Clermont-Ferrand

Unknown

Hôpital de la Croix-Rousse, Lyon

CHU de Saint-Étienne, Saint-Etienne

All Listed Sponsors
lead

Centre Jean Perrin

OTHER

NCT07178847 - cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas | Biotech Hunter | Biotech Hunter